DNA hypomethylation and proliferative activity are increased in the rectal mucosa of patients with long-standing ulcerative colitis

Cancer

Volumn 78, Issue 11, 1996, Pages 2300-2306

  Glória, Luísa ^a   Cravo, Marília ^a   Pinto, António ^a   De Sousa, L Salazar ^b   Chaves, Paula ^a   Leitäo, C Nobre ^a   Quina, Mário ^b   Mira, F Costa ^a   Soares, Jorge ^a  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^b HOSPITAL PULIDO VALENTE   (Portugal)

Author keywords

cell proliferation; colorectal carcinoma; DNA hypomethylation; flow cytometry; S phase fraction; ulcerative colitis

Indexed keywords

DNA; METHYL GROUP; METHYLTRANSFERASE; S ADENOSYLMETHIONINE; STEROID;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COLONOSCOPY; CONTROLLED STUDY; DNA METHYLATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; MALE; PLOIDY; PRIORITY JOURNAL; RECTUM MUCOSA; ULCERATIVE COLITIS;

ADULT; AGED; CELL DIVISION; COLITIS, ULCERATIVE; DNA METHYLATION; FEMALE; FLOW CYTOMETRY; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PLOIDIES; S PHASE;

EID: 0029850123     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961201)78:11<2300::AID-CNCR5>3.0.CO;2-Q     Document Type: Article

References (53)

1. Lashner BA, Silverstein MD, Hanauer SB. Hazard rates for dysplasia and cancer in ulcerative colitis: results from a surveillance program. Dig Dis Sci 1989:34:1536-44.
2. Devroede GJ, Taylor WF, Sauer WG, Jackman RJ, Stickler GB. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 1971;285:17-21.
3. Brostrom O, Lofberg R, Nordenwall B, Ost A, Hellers G. The risk of colorectal cancer in ulcerative colitis: an epidemiological study. Scand J Gastroenterol 1987;22:1193-9.
4. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer: a population based study. N Engl J Med 1990;323:1228-33.
5. Lennard-Jones, Morson BC, Ritchie JK, Shove DC, Williams CB. Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology 1977; 78:1280-9.
6. Rosenstock E, Farmer RG, Petras R, Sivak MV, Rankin GB, Sullivan BH. Surveillance for colonie cancer in ulcerative colitis. Gastroenterology 1985;89:1342-6.
7. Lashner BA, Kane SV, Hanauer SB. Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol 1990;85:1083-7.
8. Nugent FW, Haggitt RC, Gilpin PA. Cancer surveillance in ulcerative colitis. Gastroenterology 1990;100:1241-8.
9. Rutegard J, Ahsgren L, Stenling R, Janunger KG. Ulcerative colitis. Cancer surveillance in an unselected population. Scand J Gastroenterol 1988;23:139-45.
10. Lofberg R, Brostrom O, Karlén P, Tribukait B, Ost A. Colonoscopic surveillance in long-standing total ulcerative colitis - a 15 year follow-up study. Gastroenterology 1990;99:1021-31.
11. Leidenius M, Kellokumpu I, Husa A, Riihela M, Sipponen P. Dysplasia and carcinoma in long standing ulcerative colitis: an endoscopic and histological surveillance programme. Gut 1991;32:1521-5.
12. Lynch DAF, Lobo AJ, Sobala GM, Dixon MF, Axon ATR. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993;34:1075-80.
13. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990;31:800-6.
14. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical implications. Hum Pathol 1983;14:931-6.
15. Morson BC, Pang LS. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967;8:423-34.
16. Dixon MF, Brown LJR, Gilmour HM, Price AB, Smeeton NC, Talbot IC, et al. Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology 1988;13:385-98.
17. Cravo M, Glória L, Sousa LS, Chaves P, Pereira AD, Quina M, et al. Folate status, DNA methylation and colon cancer risk in inflammatory bowel disease. Clin Nutr 1995;14:50-3.
18. Hammarberg C, Slezak P, Tribukait B. Early detection of malignancy in ulcerative colitis - a flow cytometric DNA study. Cancer 1984;53:291-5.
19. Melville DM, Jass JR, Sheperd NA, Nerthover JM, Cappellaro D, Richman PI, et al. Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in ulcerative colitis. Observer variation and correlations. Gastroenterology 1988;95:668-75.
20. Lofberg R, Brostrom O, Karlen P, Ost A, Tribukait B. DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia. Gastroenterology 1992;102:1149-54.
21. Levine DS, Rabinovitch PS, Haggitt RC, Blount PL, Dean PJ, Rubin CE, et al. Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer. Gastroenterology 1991;101:1198-210.
22. Meling GI, Clausen OPF, Bergan A, Scholberg A, Rognum TO. Flow cytometric DNA ploidy pattern in dysplastic mucosa, and in primary and metastatic carcinomas in patients with longstanding ulcerative colitis. Br J Cancer 1991; 64:339-44.
23. Befrits R, Hammarberg C, Rubio C, Jaramillo E, Tribukait B. DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis. A 10-year follow-up study. Dis Colon Rectum 1994;37(4):313-9.
24. Rubin CE, Haggitt RC, Burmer CG, Brentnall TA, Stevens AC, Levine DS, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;103:1611-20.
25. Burmer GC, Rabinovitch PS, Haggitt RC, Crispin DA, Brentall TA, Colli NR, et al. Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology 1992;103:1602-10.
26. Morson BC. Rectal biopsy in inflammatory bowel disease. N Engl J Med 1972;287:1337-9.
27. Fochios SE, Korelitz BI. The role of sigmoidoscopy and rectal biopsy in diagnosis and management of inflammatory bowel disease: personal experience. Am J Gastroenterol 1988; 83:114-9.
28. Johns MB, Paulus-Thomas JE. Purification of human genomic DNA from whole blood using sodium perchlorate in place of phenol. Anal Biochem 1989;180:276-8.
29. Christman JK, Weich N, Schoenbrun B, Schneiderman N, Acs G. Hypomethylation of DNA during differentiation of Friend erythroleukemia cells. J Cell Biol 1980;86:366-79.
30. Balaghi M, Wagner C, DNA methylation in folate deficiency. Biochem Biophys Res Commun 1993;193:1184-90.
31. Deitch A, Law H, White R. A stable propidium iodide staining procedure for flow cytometry. J Histochem Cytochem 1982;30:967-72.
32. Dean P, Jett J. Mathematical analysis of DNA distributions derived from flow microfluorometry. J Cell Biol 1974;60:523-7.
33. Hiddemman W, Schumann J, Andreeff M, Barlogie B, Herman C, Leif R, et al. Convention on nomenclature for DNA cytometry. Cytometry 1984;5:445-6.
34. Fearon ER, Vogelstein B. A genetic model of colorectal tumorigenesis. Cell 1990;61:759-67.
35. Schutte B, Reynders MJ, Wiggers T, Arends JW, Volovics L, Bosman FT, et al. Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. Cancer Res 1987;47:5494-6.
36. Lipkin M. Biomarkers of increased susceptibility to gastrointestinal cancer: new applications to studies of cancer prevention in human subjects. Cancer Res 1988;48:235-45.
37. Cravo M, Pinto R, Fidalgo P, Chaves P, Glória L, Leitão CN, et al. Global DNA hypomethylation occurs in the early stages of the intestinal type of gastric carcinoma. Gut In press.
38. Sharrard RM, Royds JA, Rogers S, Shorthouse AJ. Patterns of methylation of the c-myc gene in human colorectal cancer progression. Br J Cancer 1992;65:667-72.
39. Silverman AL, Park J-G, Hamilton SR, Gazdar AF, Luk GD, Baylin SB. Abnormal methylation of the calcitonin gene in human colonie neoplasms. Cancer Res 1989;49:3468-73.
40. de Bustros A, Nelkin BD, Silverman A, Ehrlich G, Poiesz B, Baylin SB. The short arm of chromosome 11 is a "hot-spot" for hypermethylation in human neoplasia. Proc Natl Acad Sci USA 1988;85:5693-7.
41. Baylin SB, Makos M, Wu J, Yen R-CW, de Bustros A, Vertino P, et al. Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer-Cells 1991;3:383-90.
42. Counts JL, Goodman JI. Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 1995;83:13-5.
43. Kern SE. Molecular genetic profiles of colitis-associated neoplasias. Gastroenterology 1994;107:420-8.
44. Suzuki H. Microsatellite instability in ulcerative colitis-associated colorectal dysplasias and cancers. Cancer Res 1994; 54:4841-4.
45. Chaubert P, Benhattar J, Saraga E, Costa J. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol 1994; 144:767-75.
46. Yin J, Harpaz N, Tong Y, Huang Y, Laurin J, Greenwals BD, et al. p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 1993;104:1633-9.
47. Harpaz N, Peck AL, Yin J, Fiel I, Hontanosas M, Tong TR, et al. p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma. Hum Pathol 1994; 25:1069-74.
48. Roediger WEW. The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet 1980;2:712-5.
49. Roediger WEW, Nance S. Selective reduction of fatty acid oxidation in colonocytes: correlation with ulcerative colitis. Lipids 1990;25:646-52.
50. Goh HS, Jass JR. DNA content and the adenoma-carcinoma sequence in the colorectum. J Clin Pathol 1986;39:387-92.
51. Bortoluzzi F, Valentini M, Cunigoi C, Toffoli G, Boiocchi M, Poletti M, et al. DNA flow cytometric evaluation of cell cycle distribution in ulcerative colitis: a proposed method for assessing severity of disease. Gut 1995;36:50-4.
52. Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-44.
53. Taylor BA, Pemberton JH, Carpenter HA, Levin KE, Schroeder KW, Welling DR, et al. Displasia in chronic ulcerative colitis: implications for colonoscopic surveillance. Dis Colon Rectum 1992;35:950-6.